Protection from direct cerebral Cryptococcus infection by interferon-γ-dependent activation of microglial cells

Journal of Immunology

Volumn 178, Issue 9, 2007, Pages 5753-5761

  Zhou, Qing ^a   Gault, Ruth A ^b   Kozel, Thomas R ^b   Murphy, William J ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; CD45 ANTIGEN; GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG EFFICACY; FLOW CYTOMETRY; FUNGAL MENINGITIS; FUNGUS CULTURE; HOST RESISTANCE; IMMUNOTHERAPY; INTERFERON PRODUCTION; KNOCKOUT MOUSE; LYMPHOCYTE DEPLETION; MENINGOENCEPHALITIS; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RIBONUCLEASE PROTECTION ASSAY; SURVIVAL TIME;

EID: 34247554871     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.9.5753     Document Type: Article

References (57)

1. Selik, R. M., S. Y. Chu, and J. W. Ward. 1995. Trends in infectious diseases and cancers among persons dying of HIV infection in the United States from 1987 to 1992. Ann. Intern. Med. 123: 933-936.
2. Streit, W. J., J. R. Conde, S. E. Fendrick, B. E. Flanary, and C. L. Mariani. 2005. Role of microglia in the central nervous system's immune response. Neurol. Res. 27: 685-691.
3. Ladeby, R., M. Wirenfeldt, D. Garcia-Ovejero, C. Fenger, L. Dissing-Olesen, I. Dalmau, and B. Finsen. 2005. Microglial cell population dynamics in the injured adult central nervous system. Brain Res. Rev. 48: 196-206.
4. Ladeby, R., M. Wirenfeldt, I. Dalmau, R. Gregersen, D. Garcia-Ovejero, A. Babcock, T. Owens, and B. Finsen. 2005. Proliferating resident microglia express the stem cell antigen CD34 in response to acute neural injury. Glia 50: 121-131.
5. Wirenfeldt, M., A. A. Babcock, R. Ladeby, K. L. Lambertsen, F. Dagnaes-Hansen, R. G. Leslie, T. Owens, and B. Finsen. 2005. Reactive microgliosis engages distinct responses by microglial subpopulations after minor central nervous system injury. J. Neurosci. Res. 82: 507-514.
6. Banati, R. B., J. Gehrmann, and G. W. Kreutzberg. 1996. Early glial reactions in ischemic lesions. Adv. Neurol. 71: 329-336.
7. Cheeran, M. C., S. Hu, W. S. Sheng, A. Rashid, P. K. Peterson, and J. R. Lokensgard. 2005. Differential responses of human brain cells to West Nile virus infection. J. Neurovirol. 11: 512-524.
8. Aravalli, R. N., S. Hu, T. N. Rowen, J. M. Palmquist, and J. R. Lokensgard. 2005. Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J. Immunol. 175: 4189-4193.
9. Kuhlow, C. J., J. C. Garcia-Monco, J. L. Coleman, and J. L. Benach. 2005. Murine microglia are effective phagocytes for Borrelia burgdorferi. J. Neuroimmunol. 168: 183-187.
10. Suzuki, Y., J. Claflin, X. Wang, A. Lengi, and T. Kikuchi. 2005. Microglia and macrophages as innate producers of interferon-γ in the brain following infection with Toxoplasma gondii. Int. J. Parasitol. 35: 83-90.
11. Olson, J. K., and S. D. Miller. 2004. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173: 3916-3924.
12. Begum, Z., S. Sarkar, J. Mukherjee, A. Ghosh, S. Chaudhuri, and S. Chaudhuri. 2003. Evaluation of anti-tumor property of specific and non-specific BRMs in experimental gioma by assessing the microglial cell functional and phenotypic modulations. Cancer Biol. Ther. 2: 356-363.
13. Taniguchi, Y., K. Ono, S. Yoshida, and R. Tanaka. 2000. Antigen-presenting capability of glial cells under glioma-harboring conditions and the effect of glioma-derived factors on antigen presentation. J. Neuroimmunol. 111: 177-185.
14. Murata, J., P. Ricciardi-Castagnoli, P. Dessous L'Eglise Mange, F. Martin, and L. Juillerat-Jeanneret. 1997. Microglial cells induce cytotoxic effects toward colon carcinoma cells: measurement of tumor cytotoxicity with a γ-glutamyl transpeptidase assay. Int. J. Cancer 70: 169-174.
15. Miller, G. 2005. Neuroscience: the dark side of glia. Science 308: 778-781.
16. Magnus, T., B. Schreiner, T. Korn, C. Jack, H. Guo, J. Antel, I. Ifergan, L. Chen, F. Bischof, A. Bar-Or, and H. Wiendl. 2005. Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS. J. Neurosci. 25: 2537-2546.
17. Heppner, F. L., M. Greter, D. Marino, J. Falsig, G. Raivich, N. Hovelmeyer, A. Waisman, T. Rulicke, M. Prinz, J. Priller, B. Becher, and A. Aguzzi. 2005. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat. Med. 11: 146-152.
18. Ponomarev, E. D., L. P. Shriver, K. Maresz, and B. N. Dittel. 2005. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J. Neu rosci. Res. 81: 374-389.
19. Ponomarev, E. D., M. Novikova, K. Maresz, L. P. Shriver, and B. N. Dittel. 2005. Development of a culture system that supports adult microglial cell proliferation and maintenance in the resting state. J. Immunol. Methods 300: 32-46.
20. Matyszak, M. K., S. Denis-Donini, S. Citterio, R. Longhi, F. Granucci, and P. Ricciardi-Castagnoli. 1999. Microglia induce myelin basic protein-specific T cell anergy or T cell activation, according to their state of activation. Eur. J. Im munol. 29: 3063-3076.
21. Aguirre, K., and S. Miller. 2002. MHC class II-positive perivascular microglial cells mediate resistance to Cryptococcus neoformans brain infection. Glia 39: 184-188.
22. van Kooten, C., and J. Banchereau. 2000. CD40-CD40 ligand. J. Leukocyte Biol. 67: 2-17.
23. Diehl, L., A. T. Den Boer, E. I. van der Voort, C. J. Melief, R. Offringa, and R. E. Toes. 2000. The role of CD40 in peripheral T cell tolerance and immunity. J. Mol. Med. 78: 363-371.
24. Ponomarev, E. D., L. P. Shriver, and B. N. Dittel. 2006. CD40 expression by microglial cells is required for their completion of a two-step activation process during central nervous system autoimmune inflammation. J. Immunol. 176: 1402-1410.
25. Tan, J., T. Town, D. Paris, A. Placzek, T. Parker, F. Crawford, H. Yu, J. Humphrey, and M. Mullan. 1999. Activation of microglial cells by the CD40 pathway: relevance to multiple sclerosis. J. Neuroimmunol. 97: 77-85.
26. Zhou, Q., R. A. Gault, T. R. Kozel, and W. J. Murphy. 2006. Immunomodulation with CD40 stimulation and interleukin-2 protects mice from disseminated cryptococcosis. Infect. Immun. 74: 2161-2168.
27. Blasi, E., R. Barluzzi, R. Mazzolla, P. Mosci, and F. Bistoni. 1992. Experimental model of intracerebral infection with Cryptococcus neoformans: roles of phagocytes and opsonization. Infect. Immun. 60: 3682-3688.
28. Campanella, M., C. Sciorati, G. Tarozzo, and M. Beltramo. 2002. Flow cytometric analysis of inflammatory cells in ischemic rat brain. Stroke 33: 586-592.
29. Sun, K., D. E. Wilkins, M. R. Anver, T. J. Sayers, A. Panoskaltsis-Mortari, B. R. Blazar, L. A. Welniak, and W. J. Murphy. 2005. Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity. Blood 106: 3293-3299.
30. Town, T., V. Nikolic, and J. Tan. 2005. The microglial "activation" continuum: from innate to adaptive responses. J. Neuroinflammation 2: 24.
31. + T lymphocytes in host resistance against Cryptococcus neoformans in the central nervous system of immunized mice. Infect. Immun. 68: 456-462.
32. Edwards, L., A. E. Williams, A. M. Krieg, A. J. Rae, R. J. Snelgrove, and T. Hussell. 2005. Stimulation via Toll-like receptor 9 reduces Cryptococcus neoformans-induced pulmonary inflammation in an IL-12-dependent manner. Eur. J. Immunol. 35: 273-281.
33. + T cells. Clin. Exp. Immunol. 140: 220-229.
34. Blais, V., and S. Rivest. 2004. Effects of TNF-α and IFN-γ on nitric oxide-induced neurotoxicity in the mouse brain. J. Immunol. 172: 7043-7052.
35. Wensky, A. K., G. C. Furtado, M. C. Marcondes, S. Chen, D. Manfra, S. A. Lira, D. Zagzag, and J. J. Lafaille. 2005. IFN-γ determines distinct clinical outcomes in autoimmune encephalomyelitis. J. Immunol. 174: 1416-1423.
36. Benedetto, N., F. Rossano, F. Gorga, A. Folgore, M. Rao, and C. C. Romano. 2003. Defense mechanisms of IFN-γ and LPS-primed murine microglia against Acanthamoeba castellanii infection. Int. Immunopharmacol. 3: 825-834.
37. , 37. Panek, R. B., and E. N. Benveniste. 1995. Class II MHC gene expression in microglia: regulation by the cytokines IFN-γ, TNF-α, and TGF-β. J. Immunol. 154: 2846-2854.
38. + T cells. Med. Mycol. 42: 15-25.
39. Blasi, E., R. Barluzzi, R. Mazzolla, B. Tancini, S. Saleppico, M. Puliti, L. Pitzurra, and F. Bistoni. 1995. Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activity by the BV-2 microglial cell line. J. Neuroimmunol. 58: 111-116.
40. Chen, G. H., R. A. McDonald, J. C. Wells, G. B. Huffnagle, N. W. Lukacs, and G. B. Toews. 2005. The γ interferon receptor is required for the protective pulmonary inflammatory response to Cryptococcus neoformans. Infect. Immun. 73: 1788-1796.
41. De Simone, R., G. Levi, and F. Aloisi. 1998. Interferon γ gene expression in rat central nervous system glial cells. Cytokine 10: 418-422.
42. Pan, W., W. A. Banks, and A. J. Kastin. 1997. Permeability of the blood-brain and blood-spinal cord barriers to interferons. J. Neuroimmunol. 76: 105-111.
43. Collazos, J. 2003. Opportunistic infections of the CNS in patients with AIDS: diagnosis and management. CNS Drugs 17: 869-887.
44. Singh, N., O. Lortholary, B. D. Alexander, K. L. Gupta, G. T. John, K. J. Pursell, P. Munoz, G. B. Klintmalm, V. Stosor, B. R. Del, et al. 2005. Antifungal management practices and evolution of infection in organ transplant recipients with Cryptococcus neoformans infection. Transplantation 80: 1033-1039.
45. Wilson, L. S., C. M. Reyes, M. Stolpman, J. Speckman, K. Allen, and J. Beney. 2002. The direct cost and incidence of systemic fungal infections. Value Health 5: 26-34.
46. + T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract. J. Exp. Med. 175: 1685-1695.
47. Dimayuga, F. O., J. L. Reed, G. A. Carnero, C. Wang, E. R. Dimayuga, V. M. Dimayuga, A. Perger, M. E. Wilson, J. N. Keller, and A. J. Bruce-Keller. 2005. Estrogen and brain inflammation: effects on microglial expression of MHC, costimulatory molecules and cytokines. J. Neuroimmunol. 161: 123-136.
48. + T-cells. Glia 22: 348-359.
49. O'Keefe, G. M., V. T. Nguyen, and E. N. Benveniste. 2002. Regulation and function of class II major histocompatibility complex, CD40, and B7 expression in macrophages and microglia: implications in neurological diseases. J. Neurovirol. 8: 496-512.
50. Chao, C. C., S. Hu, T. W. Molitor, E. G. Shaskan, and P. K. Peterson. 1992. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149: 2736-2741.
51. Lokensgard, J. R., S. Hu, W. Sheng, M. van Oijen, D. Cox, M. C. Cheeran, and P. K. Peterson. 2001. Robust expression of TNF-α, IL-1β, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus. J. Neurovirol. 7: 208-219.
52. Maffei, C. M., L. F. Mirels, R. A. Sobel, K. V. Clemons, and D. A. Stevens. 2004. Cytokine and inducible nitric oxide synthase mRNA expression during experimental murine cryptococcal meningoencephalitis. Infect. Immun. 72: 2338-2349.
53. Vitkovic, L., J. Bockaert, and C. Jacque. 2000. "Inflammatory" cytokines: neuromodulators in normal brain? J. Neurochem. 74: 457-471.
54. Vitkovic, L., S. Maeda, and E. Sternberg. 2001. Anti-inflammatory cytokines: expression and action in the brain. Neuroimmunomodulation 9: 295-312.
55. Bava, A. J., J. Afeltra, R. Negroni, and R. A. Diez. 1995. Interferon γ increases survival in murine experimental cryptococcosis. Rev. Inst. Med. Trop. Sao Paulo 37: 391-396.
56. Clemons, K. V., J. E. Lutz, and D. A. Stevens. 2001. Efficacy of recombinant γ interferon for treatment of systemic cryptococcosis in SCID mice. Antimicrob. Agents Chemother. 45: 686-689.
57. Kullberg, B. J. 1997. Trends in immunotherapy of fungal infections. Eur. J. Clin. Microbiol. Infect. Dis. 16: 51-55.